This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grellier, P. Articles by Babajko, S. Search for Related Content PubMed PubMed Citation Articles by Grellier, P. Articles by Babajko, S.

Expression of Insulin-like Growth Factor-binding Protein 6 Complementary DNA Alters Neuroblastoma Cell Growth¹

Unité de Recherches sur la Régulation de la Croissance, U.142, Institut National de la Santé et de la Recherche Médicale, Hôpital Saint Antoine, 75571 Paris Cedex 12, France

Insulin-like growth factors I and II (IGF-I and IGF-II) are actively involved in neuroblastoma cell growth. In all biological fluids, they are noncovalently bound to high-affinity binding proteins. At least six species of these IGF-binding proteins (IGFBPs) have been identified, but their precise roles remain unclear. One of them, IGFBP-6, is produced by neuroblastoma cells in culture under certain experimental conditions and seems to be associated with the arrest of cell growth.

We stably transfected IGR-N-91 and SK-N-SH neuroblastoma cells with an expression vector comprising IGFBP-6 cDNA, whose expression was placed under the control of the constitutive and ubiquitous cytomegalovirus promoter. Analyses of the cell cycle (flux cytofluorometry), mitogenic activity (radiolabeled thymidine incorporation), and the number of viable cells (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test) showed that the mitogenic effects of serum, IGF-I, IGF-II, and des (1–3) IGF-I, a truncated IGF-I analogue with no affinity for IGFBP-6, were depressed in both transfected cell lines.

With s.c. injection of transfected IGR-N-91 cells into nude mice, tumors developed in only 50–70% of cases, 1 or 2 weeks after those in controls, and were 60–90% smaller.

Our findings show that IGFBP-6 influences neuroblastoma cell growth, both in vitro and in experimental xenograft development.

¹ Supported by the Institut National de la Santé et de la Recherche Médicale, the Association pour la Recherche sur le Cancer, and the Ligue Nationale contre le Cancer. P. G. is a recipient of a fellowship from the Ligue Nationale contre le Cancer and the Fondation pour la Recherche Médicale.

² To whom requests for reprints should be addressed, at Institut National de la Santé et de la Recherche Médicale U.142, Hôpital Saint Antoine, 184 rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France. Fax: 33-1-43-43-32-34/43-43-10-65.

Received 7/30/97. Accepted 2/17/98.

This article has been cited by other articles:

				C. Iosef, T. Gkourasas, C. Y. H. Jia, S. S.-C. Li, and V. K. M. Han A Functional Nuclear Localization Signal in Insulin-Like Growth Factor Binding Protein-6 Mediates Its Nuclear Import Endocrinology, March 1, 2008; 149(3): 1214 - 1226. [Abstract] [Full Text] [PDF]

				P. Fu, J. A. Thompson, and L. A. Bach Promotion of Cancer Cell Migration: AN INSULIN-LIKE GROWTH FACTOR (IGF)-INDEPENDENT ACTION OF IGF-BINDING PROTEIN-6 J. Biol. Chem., August 3, 2007; 282(31): 22298 - 22306. [Abstract] [Full Text] [PDF]

				S. J. Headey, D. W. Keizer, S. Yao, G. Brasier, P. Kantharidis, L. A. Bach, and R. S. Norton C-Terminal Domain of Insulin-Like Growth Factor (IGF) Binding Protein-6: Structure and Interaction with IGF-II Mol. Endocrinol., November 1, 2004; 18(11): 2740 - 2750. [Abstract] [Full Text] [PDF]

				S. J Headey, K. S Leeding, R. S Norton, and L. A Bach Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding J. Mol. Endocrinol., October 1, 2004; 33(2): 377 - 386. [Abstract] [Full Text] [PDF]

				B. L. Dake, M. Boes, L. A. Bach, and R. S. Bar Effect of an Insulin-Like Growth Factor Binding Protein Fusion Protein on Thymidine Incorporation in Neuroblastoma and Rhabdomyosarcoma Cell Lines Endocrinology, July 1, 2004; 145(7): 3369 - 3374. [Abstract] [Full Text] [PDF]

				G. Bienvenu, D. Seurin, P. Grellier, P. Froment, M. Baudrimont, P. Monget, Y. Le Bouc, and S. Babajko Insulin-Like Growth Factor Binding Protein-6 Transgenic Mice: Postnatal Growth, Brain Development, and Reproduction Abnormalities Endocrinology, May 1, 2004; 145(5): 2412 - 2420. [Abstract] [Full Text] [PDF]

				T.S. Gadd, J.C. Osgerby, and D.C. Wathes Regulation of Insulin-Like Growth Factor Binding Protein-6 Expression in the Reproductive Tract Throughout the Estrous Cycle and During the Development of the Placenta in the Ewe Biol Reprod, December 1, 2002; 67(6): 1756 - 1762. [Abstract] [Full Text] [PDF]

				N. Chen, Q.-B. She, A. M. Bode, and Z. Dong Differential Gene Expression Profiles of Jnk1- and Jnk2-deficient Murine Fibroblast Cells Cancer Res., March 1, 2002; 62(5): 1300 - 1304. [Abstract] [Full Text] [PDF]

				W Zumkeller IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol. Pathol., October 1, 2001; 54(5): 285 - 288. [Abstract] [Full Text] [PDF]

				R. H. Drivdahl, C. Sprenger, K. Trimm, and S. R. Plymate Inhibition of Growth and Increased Expression of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and -6 in Prostate Cancer Cells Stably Transfected with Antisense IGFBP-4 Complementary Deoxyribonucleic Acid Endocrinology, May 1, 2001; 142(5): 1990 - 1998. [Abstract] [Full Text]

				N. Sueoka, H.-Y. Lee, G. L. Walsh, B. Fang, L. Ji, J. A. Roth, R. LaPushin, W. K. Hong, P. Cohen, and J. M. Kurie Insulin-Like Growth Factor Binding Protein-6 Inhibits the Growth of Human Bronchial Epithelial Cells and Increases in Abundance with All-trans-Retinoic Acid Treatment Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 297 - 303. [Abstract] [Full Text]

				M. R. SCHNEIDER, H. LAHM, M. WU, A. HOEFLICH, and E. WOLF Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins FASEB J, April 1, 2000; 14(5): 629 - 640. [Abstract] [Full Text]

				D. Chambery, S. Mohseni-Zadeh, B. d. Galle, and S. Babajko N-myc Regulation of Type I Insulin-like Growth Factor Receptor in a Human Neuroblastoma Cell Line Cancer Res., June 1, 1999; 59(12): 2898 - 2902. [Abstract] [Full Text] [PDF]